Bolivia covid-19 vaccine Bolivia

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues

Reading now: 780
globalnews.ca

Johnson & Johnson/Janssen COVID-19 vaccine to Bolivia, but it cannot move ahead until it is allowed to actually produce it.Biolyse Pharma, an Ontario-based manufacturer, says it already has the capacity to produce up to 20 million doses annually of an already-approved viral-vector COVID-19 vaccine, like the AstraZeneca or Johnson & Johnson vaccines, with the potential to produce 50 million doses.However, it’s unable to do so without a voluntary licence from the patent holder, a compulsory licence through special legislation or the waiving of intellectual property rights.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA